|
NPDI-yvZDKA |
Green tea (Camellia sinensis) |
Green tea (Camellia sinensis) extract does not alter cytochrome P450 3A4 or 2D6 activity in healthy volunteers. |
2 |
|
|
NPDI-RTaSkA |
Green tea (Camellia sinensis) |
Inhibitory effects of various beverages on ritodrine sulfation by recombinant human sulfotransferase isoforms SULT1A1 and SULT1A3 |
4 |
|
|
NPDI-aujB5A |
Green tea (Camellia sinensis) |
Effects of green tea catechins on cytochrome P450 2B6, 2C8, 2C19, 2D6 and 3A activities in human liver and intestinal microsomes |
12 |
|
|
NPDI-zg6Npw |
Green tea (Camellia sinensis) |
Inhibitory effects of commonly used herbal extracts on UDP-glucuronosyltransferase 1A4, 1A6, and 1A9 enzyme activities |
3 |
|
|
NPDI-S1YNJQ |
Green tea (Camellia sinensis) |
Inhibitory effects of commonly used herbal extracts on UGT1A1 enzyme activity. |
1 |
|
|
NPDI-6yhsoA |
Green tea (Camellia sinensis) |
Effects of repeated green tea catechin administration on human cytochrome P450 activity. |
4 |
|
|
NPDI-OeAReg |
Green tea (Camellia sinensis) |
Identification of Intestinal UDP-Glucuronosyltransferase Inhibitors in Green Tea (Camellia sinensis) Using a Biochemometric Approach: Application to Raloxifene as a Test Drug via In Vitro to In Vivo Extrapolation |
24 |
|
|
NPDI-dCfz1g |
Green tea (Camellia sinensis) |
Inhibition by green tea catechins of metabolic activation of procarcinogens by human cytochrome P450 |
13 |
|
|
NPDI-FfN_4A |
Kratom (Mitragyna speciosa) |
Evaluation of the Effects of Mitragyna speciosa Alkaloid Extract on Cytochrome P450 Enzymes Using a High Throughput Assay |
4 |
|
|
NPDI-5XFThQ |
Goldenseal (Hydrastis canadensis) |
Repeated administration of berberine inhibits cytochromes P450 in humans |
5 |
|
|
NPDI-twVQgQ |
Goldenseal (Hydrastis canadensis) |
Supplementation With Goldenseal (Hydrastis canadensis), but not Kava Kava (Piper methysticum), Inhibits Human CYP3A Activity In Vivo |
1 |
|
|
NPDI-yBr48Q |
Goldenseal (Hydrastis canadensis) |
The Effects of Berberine on the Pharmacokinetics of Ciclosporin A in Healthy Volunteers |
2 |
|
|
NPDI-ftEv0g |
Goldenseal (Hydrastis canadensis) |
In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4 phenotypes |
4 |
|
|
NPDI-fLne_g |
Goldenseal (Hydrastis canadensis) |
Influence of Goldenseal Root on the Pharmacokinetics of Indinavir |
1 |
|
|
NPDI-SPpDlg |
Goldenseal (Hydrastis canadensis) |
Enzyme-inducing effects of berberine on cytochrome P450 1A2 in vitro and in vivo |
2 |
|
|
NPDI-Tq41aQ |
Goldenseal (Hydrastis canadensis) |
In Vivo and in Vitro Study on Drug-Drug Interaction of Lovastatin and Berberine from Pharmacokinetic and HepG2 Cell Metabolism Studies |
1 |
|
|
NPDI-EngCtg |
Cannabis (Cannabis sativa) |
Medicinal Cannabis Does Not Influence the Clinical Pharmacokinetics of Irinotecan and Docetaxel |
2 |
|
|
NPDI-Z6vbAA |
Cannabis (Cannabis sativa) |
Characterization of the structural determinants required for potent mechanism-based inhibition of human cytochrome P450 1A1 by cannabidiol |
4 |
|
|
NPDI-jEZ9Ng |
Goldenseal (Hydrastis canadensis) |
Differential inhibition of CYP1-catalyzed regioselective hydroxylation of estradiol by berberine and its oxidative metabolites |
2 |
|
|
NPDI-4zmpGg |
Goldenseal (Hydrastis canadensis) |
Time-Dependent Inhibition of CYP2C19 by Isoquinoline Alkaloids: In Vitro and In Silico Analysis |
1 |
|
|
NPDI-sUzV-g |
Cannabis (Cannabis sativa) |
Characterization of Human Hepatic and Extrahepatic UDP-Glucuronosyltransferase Enzymes Involved in the Metabolism of Classic Cannabinoids |
8 |
|
|
NPDI-zlH6uA |
Cannabis (Cannabis sativa) |
Identification of cytochrome P450 enzymes responsible for metabolism of cannabidiol by human liver microsomes |
4 |
|
|
NPDI-5Mf9Qw |
Goldenseal (Hydrastis canadensis) |
The Effect of Oxidation on Berberine-Mediated CYP1 Inhibition: Oxidation Behavior and Metabolite-Mediated Inhibition |
4 |
|
|
NPDI-Ujn_7A |
Cannabis (Cannabis sativa) |
Structural requirements for potent direct inhibition of human cytochrome P450 1A1 by cannabidiol: role of pentylresorcinol moiety. |
5 |
|
|
NPDI-JcMOhg |
berberine |
Inhibitory Mechanisms of Human CYPs by Three Alkaloids Isolated from Traditional Chinese Herbs |
6 |
|
|
NPDI-vhBMSw |
Cannabis (Cannabis sativa) |
Involvement of UDP-Glucuronosyltransferases UGT1A9 and UGT2B7 in Ethanol Glucuronidation, and Interactions with Common Drugs of Abuse |
6 |
|
|
NPDI-vniY7Q |
Cannabis (Cannabis sativa) |
Comparison in the in vitro inhibitory effects of major phytocannabinoids and polycyclic aromatic hydrocarbons contained in marijuana smoke on cytochrome P450 2C9 activity. |
15 |
|
|
NPDI-luckpg |
Goldenseal (Hydrastis canadensis) |
An ex vivo approach to botanical-drug interactions: A proof of concept study |
5 |
|
|
NPDI-ieYYdA |
Cannabis (Cannabis sativa) |
Cannabidiol, a major phytocannabinoid, as a potent atypical inhibitor for CYP2D6. |
12 |
|
|
NPDI-47DSLg |
Goldenseal (Hydrastis canadensis) |
Effects of Herbal Products and their Constituents on Human Cytochrome P4502E1 Activity |
3 |
|
|
NPDI-iHWMgQ |
Cannabis (Cannabis sativa) |
Potent inhibition of human cytochrome P450 3A isoforms by cannabidiol: role of phenolic hydroxyl groups in the resorcinol moiety. |
6 |
|
|
NPDI-EiXGKA |
Goldenseal (Hydrastis canadensis) |
An in vitro Evaluation of Cytochrome P450 Inhibition and P-Glycoprotein Interaction with Goldenseal, Ginkgo biloba, Grape Seed, Milk Thistle, and Ginseng Extracts and Their Constituents |
25 |
|
|
NPDI-agZaLg |
Goldenseal (Hydrastis canadensis) |
Human Cytochrome P450 Inhibition and Metabolic-Intermediate Complex Formation By Goldenseal Extract and Its Methylenedioxyphenyl Components |
12 |
|
|
NPDI-VYyv-A |
Cannabis (Cannabis sativa) |
Characterization of major phytocannabinoids, cannabidiol and cannabinol, as isoform-selective and potent inhibitors of human CYP1 enzymes |
9 |
|
|
NPDI-pHkLHA |
Goldenseal (Hydrastis canadensis) |
An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures |
1 |
|
|
NPDI-9C7QHg |
Kratom (Mitragyna speciosa) |
Effects of mitragynine and 7-hydroxymitragynine (the alkaloids of Mitragyna speciosa Korth) on 4-methylumbelliferone glucuronidation in rat and human liver microsomes and recombinant human uridine 5’- diphospho-glucuronosyltransferase isoforms |
15 |
|
|
NPDI-XtvOZQ |
Kratom (Mitragyna speciosa) |
Inhibitory effect of mitragynine on human cytochrome P450 enzyme activities |
9 |
|
|
NPDI-PSB8Vg |
Kratom (Mitragyna speciosa) |
Evaluation of selected Malaysian medicinal plants on phase I drug metabolizing enzymes, CYP2C9, CYP2D6 and CYP3A4 activities in vitro |
6 |
|
|
NPDI-9V_SXw |
Cannabis (Cannabis sativa) |
Cannabidiol is a potent inhibitor of the catalytic activity of cytochrome P450 2C19. |
4 |
|
|
NPDI-d8OUzg |
Kratom (Mitragyna speciosa) |
Refined Prediction of Pharmacokinetic Kratom-Drug Interactions: Time-Dependent Inhibition Considerations |
19 |
|
|
NPDI-8SkM4A |
Licorice (Glycyrrhiza glabra) |
Cytochrome P450 inhibition by licorice species Glycyrrhiza glabra L. and fourteen licorice constituents |
11 |
|
|
NPDI-qiyzaQ |
licoricidin |
Inhibition of CYP enzymes by licoricidin |
5 |
|
|
NPDI-Lm3PvA |
Licorice (Glycyrrhiza uralensis) |
Cytochrome P450 inhibition by licorice species Glycyrrhiza uralensis and fourteen licorice constituents |
11 |
|
|
NPDI-UmIRAQ |
Licorice (Glycyrrhiza inflata) |
Cytochrome P450 inhibition by licorice species Glycyrrhiza inflata and fourteen licorice constituents |
11 |
|
|
NPDI-N-qGfA |
glabridin |
Inhibition of CYP enzymes by glabridin |
1 |
|
|
NPDI-l4wD_A |
glycycoumarin |
Inhibition of CYP enzymes by glycycoumarin |
5 |
|
|
NPDI-OYnBGA |
glycyrrhetinic acid |
Inhibition of CYP enzymes by glycyrrhetinic acid |
2 |
|
|
NPDI-bQlJCA |
isoliquiritigenin |
Inhibition of CYP enzymes by isoliquiritigenin |
3 |
|
|
NPDI-oEAKVw |
licochalcone a |
Inhibition of CYP enzymes by licochalcone a |
10 |
|
|
NPDI-eReNjw |
Kratom (Mitragyna speciosa) |
Exploration of cytochrome P450 inhibition mediated drug-drug interaction potential of kratom alkaloids |
42 |
|
|
NPDI-r7lzqQ |
zidovudine |
Inhibition of UGT2B7 Enzyme Activity in Human and Rat Liver Microsomes by Herbal Constituents |
6 |
|
|
NPDI-lY9NZQ |
Cannabis (Cannabis sativa) |
Cannabidiol induces expression of human cytochrome P450 1A1 that is possibly mediated through aryl hydrocarbon receptor signaling in HepG2 cells |
3 |
|
|
NPDI-Rvn9SQ |
Cannabis (Cannabis sativa) |
Cytochrome P450 enzymes involved in the metabolism of tetrahydrocannabinols and cannabinol by human hepatic microsomes |
18 |
|
|
NPDI-dIgOyA |
Kratom (Mitragyna speciosa) |
Metabolite profiling and identification of enzymes responsible for the metabolism of mitragynine, the major alkaloid of Mitragyna speciosa (kratom) |
1 |
|
|
NPDI-d4aGfw |
Cannabis (Cannabis sativa) |
In Vitro Inhibition of Carboxylesterase 1 by Major Cannabinoids and Selected Metabolites |
9 |
|
|
NPDI-O4gNrA |
Goldenseal (Hydrastis canadensis) |
A clinical study of transporter-mediated goldenseal drug interactions |
5 |
|
|
NPDI-BUBqZg |
Ceylon cinnamon (Cinnamomum verum) |
Mechanisms of Herb-Drug Interactions Involving Cinnamon and CYP2A6: Focus on Time-Dependent Inhibition by Cinnamaldehyde and 2-Methoxycinnamaldehyde |
6 |
|
|
NPDI-lalKkg |
Cannabis (Cannabis sativa) |
Predicting the Potential for Cannabinoids to Precipitate Pharmacokinetic Drug Interactions via Reversible Inhibition or Inactivation of Major Cytochromes P450 |
15 |
|
|
NPDI-XnaDAw |
Coleus (Coleus forskholii) |
Coleus stem extract Nuclear Receptor Induction study - Ole Miss |
6 |
|
|
NPDI-BacmiQ |
Guggul (Commiphora mukul) |
Guggul oleo-gum resin extract Nuclear Receptor Induction study - Ole Miss |
6 |
|
|
NPDI-joEW1A |
Boswellia (Boswellia serrata) |
Boswellia resin extract Nuclear Receptor Induction study - Ole Miss |
6 |
|
|
NPDI-g-PM9w |
Coptis (Coptis chinensis) |
Coptis rhizome extract Nuclear Receptor Induction study - Ole Miss |
6 |
|
|
NPDI-k8HdOg |
Cannabis (Cannabis sativa) |
Hemp (low CBD) extract Nuclear Receptor Induction study - Ole Miss |
6 |
|
|
NPDI-paKXvg |
Aloe vera (Aloe vera) |
Aloe vera leaf extract Nuclear Receptor Induction study - Ole Miss |
6 |
|
|
NPDI-vA2ioQ |
Cannabis (Cannabis sativa) |
Hemp (high CBD) extract Nuclear Receptor Induction study - Ole Miss |
6 |
|
|
NPDI-CWch6w |
Licorice (Glycyrrhiza glabra) |
Chemical basis of pregnane X receptor activators in the herbal supplement Gancao (licorice) |
20 |
|
|
NPDI-UPO5FQ |
Shrubby sophora (Sophora flavescens) |
Chinese Herbal Medicine Sophora Flavescens Activates PXR |
20 |
|
|
NPDI-TcRn0A |
Indian barberry (Berberis aristata) |
Barberry stem extract Nuclear Receptor Induction study - Ole Miss |
3 |
|
|
NPDI-yA7l_g |
Beet root (Beta vulgaris) |
Beet root leaf extract Nuclear Receptor Induction study - Ole Miss |
3 |
|
|
NPDI-kpUP9w |
Turmeric (Curcuma longa) |
Turmeric rhizome extract Nuclear Receptor Induction study - Ole Miss |
6 |
|
|
NPDI-m8Wl_w |
Horny Goat Weed (Epimedium grandiflorum) |
Horny goat weed aerial parts extract Nuclear Receptor Induction study - Ole Miss |
6 |
|
|
NPDI-9DI3Ew |
Horsetail (Equisetum hyemale) |
Horsetail stem extract Nuclear Receptor Induction study - Ole Miss |
6 |
|
|
NPDI-OJbIDw |
Garcinia (Garcinia gummi) |
Garcinia cambogia fruit extract Nuclear Receptor Induction study - Ole Miss |
6 |
|
|
NPDI-5Vo0XQ |
Licorice (Glycyrrhiza glabra) |
Licorice root extract Nuclear Receptor Induction study - Ole Miss |
6 |
|
|
NPDI-TAWrdg |
Ivy leaf (Hedera helix) |
Ivy leaf mixed parts extract Nuclear Receptor Induction study - Ole Miss |
3 |
|
|
NPDI-uLn5Ig |
Barley grass (Hordeum vulgare) |
Barley grass seed extract Nuclear Receptor Induction study - Ole Miss |
3 |
|
|
NPDI-diarHw |
Goldenseal (Hydrastis canadensis) |
Goldenseal root extract Nuclear Receptor Induction study - Ole Miss |
6 |
|
|
NPDI-SNlg1w |
Goatweed (Hypericum perforatum) |
St. John's wort mixed parts extract Nuclear Receptor Induction study - Ole Miss |
6 |
|
|
NPDI-KpNlwA |
Maca (Lepidium meyenii) |
Maca root extract Nuclear Receptor Induction study - Ole Miss |
3 |
|
|
NPDI-JI5m9A |
Horehound (Marrubium vulgare) |
Horehound leaf extract Nuclear Receptor Induction study - Ole Miss |
6 |
|
|
NPDI-3p6SkQ |
Moringa (Moringa oleifera) |
Moringa leaf extract Nuclear Receptor Induction study - Ole Miss |
6 |
|
|
NPDI-XbFHUg |
Oregano (Origanum vulgare) |
Oregano leaf extract Nuclear Receptor Induction study - Ole Miss |
6 |
|
|
NPDI-Y8SO6A |
Yohimbe (Pausinystalia johimbe) |
Yohimbe bark extract Nuclear Receptor Induction study - Ole Miss |
6 |
|
|
NPDI-fo-66g |
Black pepper (Piper nigrum) |
Black pepper fruit extract Nuclear Receptor Induction study - Ole Miss |
6 |
|
|
NPDI-EATZ0A |
Rhodiola (Rhodiola rosea) |
Rhodiola root extract Nuclear Receptor Induction study - Ole Miss |
6 |
|
|
NPDI-TvFD4g |
Elderberry (Sambucus nigra) |
Elderberry fruit extract Nuclear Receptor Induction study - Ole Miss |
6 |
|
|
NPDI-j3Ja2Q |
Wheat grass (Triticum aestivum) |
Wheat grass grains extract Nuclear Receptor Induction study - Ole Miss |
3 |
|
|
NPDI-doKK2g |
Valerian (Valeriana officinalis) |
Valerian root extract Nuclear Receptor Induction study - Ole Miss |
6 |
|
|
NPDI-e2Zw7w |
Ashwaganda (Withania somnifera) |
Ashwagandha root extract Nuclear Receptor Induction study - Ole Miss |
6 |
|
|
NPDI-j8alQQ |
Ginger (Zingiber officinale) |
Ginger root extract Nuclear Receptor Induction study - Ole Miss |
6 |
|
|
NPDI--UmauA |
Cat's-claw (Uncaria tomentosa) |
Identification of PXR activators from Uncaria tomentosa (Cat’s Claw) |
24 |
|
|
NPDI-O6q4mg |
Gou Teng (Uncaria rhynchophylla) |
Identification of PXR activators from Uncaria rhynchophylla (Gou Teng) |
28 |
|
|
NPDI-osTXuQ |
Kratom (Mitragyna speciosa) |
Clinical Assessment of the Drug Interaction Potential of the Psychotropic Natural Product Kratom |
2 |
|
|
NPDI-_cMj4g |
Cannabis (Cannabis sativa) |
Warfarin dose adjustment required after cannabidiol initiation and titration |
0 |
|
|
NPDI-7x0lVQ |
Kratom (Mitragyna speciosa) |
Fatal combination of mitragynine and quetiapine - a case report with discussion of a potential herb-drug interaction |
0 |
|
|
NPDI-y64ahQ |
Green tea (Camellia sinensis) |
The effect of green tea on simvastatin tolerability |
0 |
|
|
NPDI-azPVSg |
Barbary matrimony-vine (Lycium barbarum) |
Flecainide toxicity associated with the use of goji berries: a case report: warfarin |
0 |
|
|
NPDI-fvrNwA |
Horny Goat Weed (Epimedium grandiflorum) |
Herba Epimedii and Increased Opioid Cravings While on Buprenorphine: A Case Report |
0 |
|
|
NPDI-kVw4tA |
Green tea (Camellia sinensis) |
When Green Becomes Mean: Green Tea Extract Reduces Ziprasidone's Effect and Causes Psychosis |
0 |
|
|
NPDI-WFgDZg |
Ginger (Zingiber officinale) |
Case Report: Fatigue and Bleeding in a Polymedicated Patient Using Several Herbal Supplementations |
0 |
|
|
NPDI-veOxuw |
Barbary matrimony-vine (Lycium barbarum) |
Flecainide toxicity associated with the use of goji berries: a case report: flecainide |
0 |
|
|
NPDI-4xNSSg |
Kratom (Mitragyna speciosa) |
Evaluation of In Vitro Absorption, Distribution, Metabolism, and Excretion (ADME) Properties of Mitragynine, 7-Hydroxymitragynine, and Mitraphylline |
8 |
|
|
NPDI-K89fCg |
Green tea (Camellia sinensis) |
Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E. |
8 |
|
|
NPDI-BvR0Pw |
Cannabis (Cannabis sativa) |
Pharmacological Effects of Cannabinoids on the Caco-2 Cell Culture Model of Intestinal Permeability |
2 |
|
|
NPDI-f1iDGA |
Kratom (Mitragyna speciosa) |
Clinical Pharmacokinetic Assessment of Kratom (Mitragyna speciosa), a Botanical Product with Opioid-like Effects, in Healthy Adult Participants |
6 |
|
|
NPDI-UXOaUA |
Cannabis (Cannabis sativa) |
A phase I study to assess the effect of food on the single dose bioavailability of the THC/CBD oromucosal spray |
6 |
|
|
NPDI-iLBKJw |
Goldenseal (Hydrastis canadensis) |
R21 Goldenseal Project |
12 |
|
|
NPDI-2mUT0A |
Green tea (Camellia sinensis) |
Testing Green Tea as a Precipitant of Natural Product-Drug Interactions Using Raloxifene as the Object Drug |
2 |
|
|
NPDI-SiYA_A |
Cannabis (Cannabis sativa) |
Drug Approval Package: Epidiolex (Cannabidiol) |
14 |
|
|
NPDI-JHPnhA |
Kratom (Mitragyna speciosa) |
The inhibitory effects of mitragynine on P-glycoprotein in vitro |
9 |
|
|
NPDI-cM9pfg |
Cannabis (Cannabis sativa) |
The effects of cannabinoids on P-glycoprotein transport and expression in multidrug resistant cells. |
6 |
|
|
NPDI-7LwuzA |
Green tea (Camellia sinensis) |
Inhibitory Effects of Green Tea and (-)-Epigallocatechin Gallate on Transport by OATP1B1, OATP1B3, OCT1, OCT2, MATE1, MATE2-K and P-Glycoprotein |
18 |
|
|
NPDI-utgZiA |
Green tea (Camellia sinensis) |
Plasma pharmacokinetics of catechin metabolite 4'-O-Me-EGC in healthy humans |
1 |
|
|
NPDI-xYeUJQ |
Cannabis (Cannabis sativa) |
Influence of cannabidiol on secobarbital effects and plasma kinetics |
3 |
|
|
NPDI-1wiJBw |
Cannabis (Cannabis sativa) |
Cannabidiol changes P-gp and BCRP expression in trophoblast cell lines. |
15 |
|
|
NPDI-l0yevQ |
Cannabis (Cannabis sativa) |
CB2 and TRPV1 receptors mediate cannabinoid actions on MDR1 expression in multidrug resistant cells |
2 |
|
|
NPDI-2P3dUg |
Cannabis (Cannabis sativa) |
Cannabis extract (THC) Characterization of Material |
1 |
|
|
NPDI-rmRb0A |
Goldenseal (Hydrastis canadensis) |
Effects of berberine on the blood concentration of cyclosporin A in renal transplanted recipients: clinical and pharmacokinetic study |
2 |
|
|
NPDI--2FOpA |
Green tea (Camellia sinensis) |
Pharmacokinetics and Safety of Green Tea Polyphenols after Multiple-Dose Administration of Epigallocatechin Gallate and Polyphenon E in Healthy Individuals |
1 |
|
|
NPDI-euNEwQ |
Cannabis (Cannabis sativa) |
Cannabidiol enhances xenobiotic permeability through the human placental barrier by direct inhibition of breast cancer resistance protein: an ex vivo study. |
3 |
|
|
NPDI-m-U3YQ |
Cannabis (Cannabis sativa) |
The multidrug transporter ABCG2 (BCRP) is inhibited by plant-derived cannabinoids. |
3 |
|
|
NPDI-6PgT2w |
Kratom (Mitragyna speciosa) |
Kratom Metabolomics |
1 |
|
|
NPDI-uPn_2w |
Cannabis (Cannabis sativa) |
Enhanced biotransformation of theophylline in marihuana and tobacco smokers. |
3 |
|
|
NPDI-rRRoQw |
Goldenseal (Hydrastis canadensis) |
Inhibition of organic cation transporter 2 and 3 may be involved in the mechanism of the antidepressant-like action of berberine |
3 |
|
|
NPDI-ahQtSQ |
Cannabis (Cannabis sativa) |
Interaction of plant cannabinoids with the multidrug transporter ABCC1 (MRP1) |
6 |
|
|
NPDI-i4m0FA |
Cannabis (Cannabis sativa) |
Cannabis Characterization of Bulk Plant Material |
1 |
|
|
NPDI--aO6Bw |
Goldenseal (Hydrastis canadensis) |
Identification of novel dietary phytochemicals inhibiting the efflux transporter breast cancer resistance protein (BCRP/ABCG2) |
2 |
|
|
NPDI-ZfxNfg |
Goldenseal (Hydrastis canadensis) |
Vectorial transport of the plant alkaloid berberine by double-transfected cells expressing the human organic cation transporter 1 (OCT1, SLC22A1) and the efflux pump MDR1 P-glycoprotein (ABCB1) |
3 |
|
|
NPDI-Yknaag |
Kratom (Mitragyna speciosa) |
P-glycoprotein interactions of novel psychoactive substances – Stimulation of ATP consumption and transport across Caco-2 monolayers |
2 |
|
|
NPDI-vQCHYg |
Kratom (Mitragyna speciosa) |
Characterization of Kratom material |
1 |
|
|
NPDI-qOTUkQ |
Cannabis (Cannabis sativa) |
The effects of cannabinoids on the pharmacokinetics of indinavir and nelfinavir |
2 |
|
|
NPDI-ZqVOgw |
Cannabis (Cannabis sativa) |
Interaction between naltrexone and oral THC in heavy marijuana smokers |
1 |
|
|
NPDI-uO_CeA |
Goldenseal (Hydrastis canadensis) |
Inhibition of P-Glycoprotein by HIV Protease Inhibitors Increases Intracellular Accumulation of Berberine in Murine and Human Macrophages |
3 |
|
|
NPDI-FhBdoQ |
Cannabis (Cannabis sativa) |
Interaction of drugs of abuse and maintenance treatments with human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2). |
2 |
|
|
NPDI-dBrDOg |
Goldenseal (Hydrastis canadensis) |
Human MDR1 and MRP1 Recognize Berberine as Their Transport Substrate |
1 |
|
|
NPDI-UC_DUA |
Green tea (Camellia sinensis) |
Blood and Urine Levels of Tea Catechins after Ingestion of Different Amounts of Green Tea by Human Volunteers |
3 |
|
|
NPDI-muoDdQ |
Cannabis (Cannabis sativa) |
Cannabis extract (CBD) Characterization of Material |
1 |
|
|
NPDI-8lgFiA |
Cannabis (Cannabis sativa) |
Interaction between Marihuana and Ethanol: Effects on Psychomotor Performance |
3 |
|
|
NPDI-Em0b2g |
Goldenseal (Hydrastis canadensis) |
Goldenseal Characterization of Material |
1 |
|
|
NPDI-Szj4NQ |
Green tea (Camellia sinensis) |
Green tea ingestion greatly reduces plasma concentrations of nadolol in healthy subjects. |
3 |
|
|
NPDI-sv6smA |
Goldenseal (Hydrastis canadensis) |
Goldenseal Metabolomics |
1 |
|
|
NPDI-XM-YzA |
Green tea (Camellia sinensis) |
Green Tea Characterization of Material |
1 |
|
|
NPDI-hKjwcg |
Goldenseal (Hydrastis canadensis) |
Organic anion-transporting polypeptides contribute to the hepatic uptake of berberine |
2 |
|
|
NPDI-gTt8Dw |
Cannabis (Cannabis sativa) |
Safety and pharmacokinetics of oral cannabidiol when administered concomitantly with intravenous fentanyl in humans |
1 |
|
|
NPDI-UaGLOg |
Cannabis (Cannabis sativa) |
Characterization of P-glycoprotein Inhibition by Major Cannabinoids from Marijuana |
1 |
|
|
NPDI-jCrpqg |
Green tea (Camellia sinensis) |
Green Tea Metabolomics |
1 |
|
|
NPDI-C-vzvw |
Goldenseal (Hydrastis canadensis) |
Poor permeability and absorption affect the activity of four alkaloids from Coptis |
2 |
|
|
NPDI-rREhEQ |
Goldenseal (Hydrastis canadensis) |
Tetrandrine Potentiates the Hypoglycemic Efficacy of Berberine by Inhibiting P-Glycoprotein Function |
1 |
|
|
NPDI-Asg_wA |
Cannabis (Cannabis sativa) |
Does olanzapine inhibit the psychomimetic effects of Δ9-tetrahydrocannabinol? |
1 |
|
